| Identification | Back Directory | [Name]
4-[9-hydroxy-2-[5-[5-[6-hydroxy-3,5-dimethyl-6-(phenylcarbamoyloxymeth yl)oxan-2-yl]-3-methyl-oxolan-2-yl]-5-methyl-oxolan-2-yl]-2,8-dimethyl -1,6-dioxaspiro[4.5]dec-7-yl]-2-methyl-3-propanoyloxy-pentanoic acid | [CAS]
101191-83-7 | [Synonyms]
laidlomycin phenylcarbamate
Monensin, 16-deethyl-3-O-demethyl-16-methyl-3-O-(1-oxopropyl)-, 26-(phenylcarbamate) (9CI)
4-[9-hydroxy-2-[5-[5-[6-hydroxy-3,5-dimethyl-6-(phenylcarbamoyloxymeth yl)oxan-2-yl]-3-methyl-oxolan-2-yl]-5-methyl-oxolan-2-yl]-2,8-dimethyl -1,6-dioxaspiro[4.5]dec-7-yl]-2-methyl-3-propanoyloxy-pentanoic acid | [Molecular Formula]
C44H67NO13 | [MOL File]
101191-83-7.mol | [Molecular Weight]
818 |
| Hazard Information | Back Directory | [Description]
Laidlomycin phenylcarbamate is a semi-synthetic polyether antibiotic. | [Uses]
Laidlomycin phenylcarbamate is a semisynthetic polyether antibiotic with antiparasitic activity[1]. | [References]
[1] Clark RD, et al. Laidlomycin phenylcarbamate, a semisynthetic polyether antibiotic. J Antibiot (Tokyo). 1986 Dec;39(12):1765-8. DOI:10.7164/antibiotics.39.1765 |
|
|